Peripheral Vascular Stent Market is Expected to Reach an Estimated US$ 8,878.00 million by 2034 with a CAGR of 7.60% from 2024 to 2034 | Future Market Insights, Inc. [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
The major drivers for this market are expansion of the elderly demographic, increasing incidence of peripheral vascular conditions, growing demand for minimal invasive treatment options, and an upsurge in tobacco usage rates. NEWARK, Del, April 22, 2024 (GLOBE NEWSWIRE) -- The peripheral vascular stent market value is expected to rise from US$ 4,267.70 million in 2024 to US$ 8,878.00 million by 2034. This market is analyzed to surge ahead at a CAGR of over the next decade. The demand for peripheral vascular stents is erupting as more people suffer from cardiovascular diseases (CVDs). These diseases are severe and are one of the leading causes of death worldwide. For patients with high-risk cardiovascular disease, the execution of stents has become a top device used to treat obstructive coronary disease. Increasing use of peripheral vascular stents to alleviate symptoms of obstructive coronary artery diseases is propelling market growth. Industry participants are thus incessantly
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Global PTCA Drug Coated Balloon Catheters Pipeline Insights: 2024 Update on Developmental Stages, Regulatory Paths, and Key Market Players [Yahoo! Finance]Yahoo! Finance
- Global Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation (BSX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Becton Dickinson lifts profit view on strong surgical equipment demand [Yahoo! Finance]Yahoo! Finance
- Teleflex beats quarterly profit estimates on healthy demand for medical devices [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 5/2/24 - Form 4
- 5/2/24 - Form 4
- 5/1/24 - Form 144
- BSX's page on the SEC website